17 April 2017

HNL TRADE Co. -- Main Portfolio

Watchlist -- 18 April 2017

Pending Trades:

Limit Sell 172 shares of AA @ $35.14 (0%)

Limit Sell 392 shares of ACET @ $16.11 (5%)

Limit Sell 513 shares of CYTK @ $12.30 (5%)

Limit Sell 904 shares of MDR @ $7.00 (5%)

Limit Sell 306 shares of MGNX @ $19.60 (0%)

Limit Sell 1240 shares of OMED @ $5.04 (5%)

Limit Sell 316 shares of RES @ $19.96 (5%)

Limit Sell 346 shares of UA @ $19.48 (5%)

Limit Sell 121 shares of USB @ $54.09 (5%)

Purchases:

N/A

Sells:

N/A

Thoughts:

OMED killed us today -- on what should have been a +3% type day. OMED suspended testing on another drug...it's not good; for the short term anyway. They have solid cash flow and multiple drugs; long term it's going to be okay, but we're probably stuck with it for a while. We still expect a rebound, it's definitely oversold, but probably not a 20% rebound like we'd need. Don't worry, stick with the system -- it works. Happy Trading!

AA - Systematic investing. 5% and out.

ACET - Systematic investing. 5% and out.

CYTK - Systematic Investing. 5% and out.

MDR - Systematic investing. 5% and out.

MGNX - Systematic investing. 5% and out.

OMED - Systematic investing. 5% and out.

RES - Systematic investing. 5% and out.

UA - Systematic investing. 5% and out.

USB - Systematic Investing. 5% and out.

ACOR - Great potential -- just beginning coverage. Hopefully will remain stagnant for a few days for monitoring and us to develop some free capital.

AMSWA - Monitoring.

AUO - Monitoring. Desired re-entry of $4.00.

CNQ - Monitoring -- We probably missed the easy money on this. Will continue to monitor for a week or so, but it's probably already gone.

CPG - Monitoring -- We probably missed the easy money on this. Will continue to monitor for a week or so, but it's probably already gone.

FOMX - There's some risk with this stock, but a lot of upside. Would like to see this trade down over the next week or so (with some luck), if the price is stable or cheaper, it becomes an excellent buy.

GLYC - We've been searching for a pharmaceutical with big gain potential and this could be it.

SHOP - This stock is out of sight right now...unfortunately. We have a history, so we'll keep an eye on it. Looks very overbought.

SSW - The whole shipping industry is suffering as a whole right now, but when, not if, it recovers Seaspan will once again lead the pack. Still a little risky at the moment. Monitoring.

UPS - Safe. Slow. Reasonable amount of upside for a $100 stock. 

VSTM - Sold @ $1.39. Desired re-entry @ $1.30. Target Price $2.50

James PauleyComment